pharma

  1. Launch of Dr. Satya Vadlamani's biography during 22nd Asian Business and Social Forum 2024: Mumbai

    Launch of Dr. Satya Vadlamani's biography during 22nd Asian Business and Social Forum 2024: Mumbai

    Mumbai (Maharashtra) [India], May 18: AsiaOne successfully organized the 22nd edition of the Asian Business and Social Forum, a premier event held in the dynamic city of Mumbai, India. Scheduled as an extensive one-day event, this prestigious gathering served as a nexus to cross boundaries and...
  2. Government reduced prices of 41 medicines

    Government reduced prices of 41 medicines

    According to a notification issued by the Department of Pharmaceuticals and the National Pharmaceutical Pricing Authority (NPPA), antacids, multivitamins and antibiotics are among the medicines that will become cheaper.Pharma companies have been instructed to inform the dealers and stockists...
  3. Mankind Pharma's net profit rises 62 percent to Rs 477 crore in fourth quarter

    Mankind Pharma's net profit rises 62 percent to Rs 477 crore in fourth quarter

    New Delhi: Mankind Pharma on Wednesday said its consolidated profit rose 62 per cent to Rs 477 crore in the March quarter.The drugmaker had reported a profit after tax (PAT) of Rs 294 crore for the January-March period of FY2013.Revenue from operations increased to Rs 2,441 crore in the...
  4. Punjab Police busts interstate drugs smuggling gang, 7 arrested

    Punjab Police busts interstate drugs smuggling gang, 7 arrested

    Chandigarh, Punjab Police has busted an interstate network of illegal drugs manufacturing and supply units in Himachal Pradesh and arrested seven drug suppliers, including the mastermind of their gang. Officials gave this information on Saturday.During the entire operation spread across five...
  5. Punjab Police busts interstate illegal pharma supply and manufacturing network

    Punjab Police busts interstate illegal pharma supply and manufacturing network

    Amritsar (Punjab) [India], Punjab Police busted an inter-state illegal pharmaceutical supply and manufacturing network operating from a pharma factor in Himachal Pradesh, a senior officer said on Saturday, following a major intelligence-gathering against pharma opioids. In a raid based...
  6. Lupine appoints Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors

    Lupine appoints Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors

    New Delhi, Pharma major Lupine Ltd on Thursday announced the appointment of former Pfizer Chairman and CEO, Jeffrey Kindler and Alfonso 'Chito' Zulueta as independent directors to its board.Lupine said in a regulatory filing that Kindler is currently the CEO of Centrexion Therapeutics, a...
  7. USFDA issues Form 483 to Cipla Kurkumbh unit with 1 inspectional observation

    USFDA issues Form 483 to Cipla Kurkumbh unit with 1 inspectional observation

    New Delhi: Pharma major Cipla Ltd on Wednesday said it has received inspection observation in Form 483 from the US health regulator for its manufacturing facility in Kurkumbh, Maharashtra.According to the U.S. Food and Drug Administration (USFDA), Form 483 is issued to a firm's management at...
  8. Dr Reddy's Laboratories reports 36 per cent rise in fourth quarter net profit

    Dr Reddy's Laboratories reports 36 per cent rise in fourth quarter net profit

    The Hyderabad-based pharma major reported 12 per cent growth in total revenue to Rs 7,083 crore as against Rs 6,297 crore in the fourth quarter last year.Dr Reddy's board declared a final dividend of Rs 40 per share (800 per cent) or Rs 5 for the financial year 2023-24, the company said in a...
  9. Gland Pharma gets USFDA approval for generic edaravone injection

    Gland Pharma gets USFDA approval for generic edaravone injection

    New Delhi, Gland Pharma Ltd on Tuesday said it has received approval from the US health regulator for generic edaravone injection for the treatment of amyotrophy lateral sclerosis.Glen Pharma said in a regulatory filing that the approval by the US Food and Drug Administration (USFDA) is for...
  10. Aurobindo Pharma faces tax demand of over Rs 13 crore including interest, penalty

    Aurobindo Pharma faces tax demand of over Rs 13 crore including interest, penalty

    New Delhi, Aurobindo Pharma Ltd on Friday said it has received a tax demand of over Rs 13 crore, including interest and penalty, from the GST authority on ineligible input tax credit claim.The Deputy Commissioner of GST (ST) STU-1, Panjagutta Division, Hyderabad Commercial Taxes Department...
  11. Ajanta Pharma's net profit rises 66 percent to Rs 203 crore in fourth quarter

    Ajanta Pharma's net profit rises 66 percent to Rs 203 crore in fourth quarter

    New Delhi, Ajanta Pharma on Thursday said its consolidated net profit rose 66 per cent to Rs 203 crore in the March quarter due to strong sales in the domestic and international markets.The drugmaker had reported a net profit of Rs 122 crore in the January-March quarter of the last financial...
  12. Pharma industry leaders say India is becoming attractive for clinical trials

    Pharma industry leaders say India is becoming attractive for clinical trials

    BOSTON: Over the last 10 years, clinical trials in India have become more easy, accessible and quick, as multinational companies increasingly look to the country as their base for clinical trials, pharma sector experts have said.Data from 2017 to 2023 shows that phase two and phase three...
  13. Fire breaks out in pharma company near Hyderabad, all employees rescued safely (Lead)

    Fire breaks out in pharma company near Hyderabad, all employees rescued safely (Lead)

    Around 30-40 employees trapped inside Alvin Pharma came out safely or were rescued by fire personnel, a police officer said.An employee was injured when he jumped from a window to save himself. He was admitted to a hospital.The police lauded the heroic act of local boy Sai Charan, who helped...
  14. India's pharma exports grow 10 percent to US$27.9 billion in FY24

    India's pharma exports grow 10 percent to US$27.9 billion in FY24

    New Delhi: The country's drug and pharmaceutical exports are set to grow by 9.67 per cent year-on-year to USD 27.9 billion in 2023-24, while overall exports declined by 3 per cent in the previous fiscal.According to Commerce Ministry data, pharma exports increased by 12.7 percent to $2.8...
  15. Lupine launches new generic drug in US market

    Lupine launches new generic drug in US market

    Mirabegron extended-release tablets, 25 mg is a generic equivalent of Mirabetric® extended-release tablets, 25 mg Astellas Pharma Global Development Inc. said the Mumbai-headquartered company said.According to Lupine's statement, annual sales in the US market for Mirabegron extended-release...
  16. India's role in the medical products sector represents both a unique opportunity and a significant responsibility: FDA Commissioner

    India's role in the medical products sector represents both a unique opportunity and a significant responsibility: FDA Commissioner

    WASHINGTON: India's role in the medical products sector represents both a unique opportunity and a significant responsibility, the head of the US Food and Drug Administration has said ahead of the annual India-US Biopharma Healthcare Summit.The summit will take place in Boston this weekend...
  17. USFDA pulls up Natco Pharma for manufacturing defects at Telangana plant

    USFDA pulls up Natco Pharma for manufacturing defects at Telangana plant

    New Delhi: Natco Pharma failed to maintain cleanliness and sterilize equipment and utensils at appropriate intervals at its Telangana plant, according to the health regulator.In a warning letter to the company, the US Food and Drug Administration said investigators found various violations at...
  18. Cipla fined Rs 1.83 crore for claiming inadmissible transitional credit on education cess

    Cipla fined Rs 1.83 crore for claiming inadmissible transitional credit on education cess

    New Delhi: Pharma major Cipla Ltd on Friday said it has been fined Rs 1.83 crore by the GST authority for claiming inadmissible transition credit on education cess.The company has received an order from the Principal Commissioner of CGST Central Excise, Mumbai, Maharashtra, imposing a penalty...
  19. USFDA issues Form 483 with five inspectional observations to Marksons Pharma Goa unit

    USFDA issues Form 483 with five inspectional observations to Marksons Pharma Goa unit

    New Delhi: Marksons Pharma Ltd on Thursday said the US health regulator has issued a Form 483 with five inspectional observations after inspecting its manufacturing facility at Vema in Goa.The US Food and Drug Administration (USFDA) had conducted a routine Good Good Manufacturing Practices...
  20. Complaint filed by Fresenius Kabi against Natco Pharma in US

    Complaint filed by Fresenius Kabi against Natco Pharma in US

    New Delhi, Natco Pharma on Thursday said that a complaint has been filed against it in a US district court by Fresenius Kabi regarding the marketing of Diazepa injection prefilled syringes in the country.Fresenius Kabi USA, LLC and Fresenius Kabi Deutschland GmbH have filed a complaint against...
Back
Top